Pacira Pharmaceuticals buy Raymond James
Start price
20.12.23
/
50%
€29.60
Target price
20.12.24
€38.31
Performance (%)
-38.51%
End price
21.12.24
€18.20
Summary
This prediction ended on 21.12.24 with a price of €18.20. Massive losses of -38.51% were the result for the BUY prediction by Raymond_James. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 5.714% | 5.714% | 20.000% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Raymond_James for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $42.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.10
31.07.24
31.07.24
€34.20
31.07.25
31.07.25
-5.24%
01.08.25
01.08.25
